OPTIGEN Trademark

Trademark Overview


On Thursday, June 10, 2021, a trademark application was filed for OPTIGEN with the United States Patent and Trademark Office. The USPTO has given the OPTIGEN trademark a serial number of 90766956. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by Musculoskeletal Transplant Foundation. The OPTIGEN trademark is filed in the Pharmaceutical Products category with the following description:

human allograft tissue
optigen

General Information


Serial Number90766956
Word MarkOPTIGEN
Filing DateThursday, June 10, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and Serviceshuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMusculoskeletal Transplant Foundation
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressEdison, NJ 08837

Party NameMusculoskeletal Transplant Foundation
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressEdison, NJ 08837

Trademark Events


Event DateEvent Description
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 30, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, March 2, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 2, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, March 2, 2022SUSPENSION LETTER WRITTEN
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 14, 2021NEW APPLICATION ENTERED

Related Keywords


optigen tissue allograft human